Innovate UK has opened its ‘Biomedical Catalyst 2022 Round 1: Industry-led Research and Development’ fund for UK-registered micro, small or medium-sized enterprises wishing to develop innovative solutions to healthcare challenges. Applications can be made from 28 March 2022 until 25 May 2022.

Cadw mi gei

What type of projects are relevant?

Up to £15 million of funding is available for pre-market research and development projects with demonstrable commercial and technical feasibility. Projects can focus on any health or healthcare sector or discipline such as:

  • Disease prevention and proactive management of health and chronic conditions
  • Earlier and improved detection and diagnosis of disease to increase patient outcomes
  • Tailored treatments that change the underlying disease or offer potential cures
  • The development of digital health technologies

Projects can include activities such as:

  • Experimental evaluation at a laboratory scale
  • Use of in vitro and in vivo models to evaluate proof of concept or safety
  • Exploring potential production mechanisms
  • Prototyping
  • Product development planning
  • Intellectual property protection
  • Demonstrating clinical utility and effectiveness
  • Demonstrating safety and efficacy (including phase 1 and 2 clinical trials)
  • Regulatory planning

Organisations can apply alone or in collaboration with businesses, academic institutions, charities, not-for-profits, public sector organisations or research and technology organisations (RTOs).

Total project costs must be between £150,000 and £4 million, with grant requests for up to £2 million. Projects must start by 1st December 2022 and end by 30th November 2025 and last from 6 to 36 months. All work must be conducted in the UK, with results exploited from or within the UK.

Where can I learn more?

Please see the Innovation Funding Service webpages for more information and contact for support with collaborative applications.